IRONWOOD PHARMACEUTICALS INC (IRWD) Stock Analyst Earnings Estimates
NASDAQ:IRWD - Nasdaq - US46333X1081 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 413.753M 6.23% | 410.596M -0.76% | 442.735M 7.83% | 361.81M -18.28% | 293.33M -18.93% | 341.09M 16.28% | 543.73M 59.41% | 542.13M -0.29% | 543.15M 0.19% | 543.15M | 547.23M 0.75% | 566.61M 3.54% | |
| EBITDA YoY % growth | 233.629M 45.93% | 251.755M 7.76% | 169.911M -32.51% | 90.236M -46.89% | 88.23M -2.22% | 139.71M 58.35% | 434.11M 210.72% | 319.26M -26.46% | 257.04M -19.49% | 216.24M -15.87% | 272.34M 25.94% | N/A | |
| EBIT YoY % growth | 232.106M 48.31% | 250.337M 7.85% | 168.336M -32.76% | 84.905M -49.56% | 55.529M -34.60% | 106.18M 91.22% | 251.63M 136.98% | 248.37M -1.30% | 263.67M 6.16% | 260.1M -1.35% | 268.77M 3.33% | 289.68M 7.78% | |
| Operating Margin | 56.10% | 60.97% | 38.02% | 23.47% | 18.93% | 31.13% | 46.28% | 45.81% | 48.54% | 47.89% | 49.11% | 51.13% | |
| EPS YoY % growth | 1.18 49.37% | 0.97 -17.80% | 0.64 -34.02% | 0.09 -96.88% | 0.24 1,080.14% | 0.51 114.92% | 1.22 141.29% | 1.30 5.83% | 1.40 8.27% | 1.46 4.00% | 1.33 -9.09% | 1.41 6.15% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.02 187.98% | 0.07 | 0.09 337.33% | 0.06 208.55% | 0.06 247.83% | 0.03 -57.60% | 0.03 -65.01% | 0.02 -66.94% |
| Revenue Q2Q % growth | 68.707M -8.24% | 74.888M -20.67% | 76.194M -16.81% | 78.01M -13.85% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 11.764M -1.72% | 18.87M -32.76% | 23.426M -13.81% | 28.73M 19.01% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.204M -89.49% | 11.138M -58.82% | 19.196M -25.17% | 23.766M 12.89% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 0.02 300.00% | 0.08 | -0.06 | -74.94% |
| Q3 2024 Q2Q % growth | 0.02 -77.78% | 0.08 | -0.06 | -75.67% |
| Q2 2024 Q2Q % growth | 0.00 -100.00% | 0.16 | -0.16 | -100.00% |
| Q1 2024 Q2Q % growth | -0.02 -108.00% | 0.19 | -0.21 | -110.27% |
| Q4 2023 Q2Q % growth | -0.01 -103.70% | 0.21 | -0.22 | -104.77% |
| Q3 2023 Q2Q % growth | 0.09 -67.86% | 0.16 | -0.07 | -43.98% |
| Q2 2023 Q2Q % growth | 0.31 47.62% | 0.25 | 0.06 | 23.21% |
| Q1 2023 Q2Q % growth | 0.25 19.05% | 0.25 | 0.00 | 1.07% |
| Q4 2022 Q2Q % growth | 0.27 | 0.28 | -0.01 | -1.96% |
| Q3 2022 Q2Q % growth | 0.28 -15.15% | 0.27 | 0.01 | 3.59% |
| Q2 2022 Q2Q % growth | 0.21 -38.24% | 0.30 | -0.09 | -30.21% |
| Q1 2022 Q2Q % growth | 0.21 -12.50% | 0.26 | -0.05 | -19.26% |
| Q4 2021 Q2Q % growth | 0.27 -25.00% | 0.36 | -0.09 | -25.08% |
| Q3 2021 Q2Q % growth | 0.33 43.48% | 0.32 | 0.01 | 4.36% |
| Q2 2021 Q2Q % growth | 0.34 112.50% | 0.23 | 0.11 | 44.93% |
| Q1 2021 Q2Q % growth | 0.24 500.00% | 0.21 | 0.03 | 14.22% |
| Q4 2020 Q2Q % growth | 0.36 20.00% | 0.29 | 0.07 | 22.38% |
| Q3 2020 Q2Q % growth | 0.23 -42.50% | 0.16 | 0.07 | 48.35% |
| Q2 2020 Q2Q % growth | 0.16 60.00% | 0.09 | 0.07 | 78.25% |
| Q1 2020 Q2Q % growth | 0.04 115.38% | 0.05 | -0.01 | -21.57% |
| Q4 2019 Q2Q % growth | 0.30 | 0.24 | 0.06 | 24.40% |
| Q3 2019 Q2Q % growth | 0.40 | 0.11 | 0.29 | 251.93% |
| Q2 2019 Q2Q % growth | 0.10 | -0.03 | 0.13 | 441.48% |
| Q1 2019 Q2Q % growth | -0.26 | -0.14 | -0.12 | -88.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 90.55M -22.97% | 95.698M | -5.148M | -5.38% |
| Q3 2024 Q2Q % growth | 91.592M -19.47% | 93.073M | -1.481M | -1.59% |
| Q2 2024 Q2Q % growth | 94.396M -12.09% | 109.14M | -14.744M | -13.51% |
| Q1 2024 Q2Q % growth | 74.877M -28.05% | 107.92M | -33.043M | -30.62% |
| Q4 2023 Q2Q % growth | 117.553M 9.66% | 119.83M | -2.277M | -1.90% |
| Q3 2023 Q2Q % growth | 113.739M 4.70% | 115.15M | -1.411M | -1.23% |
| Q2 2023 Q2Q % growth | 107.382M 10.44% | 105.79M | 1.592M | 1.50% |
| Q1 2023 Q2Q % growth | 104.061M 6.70% | 102.42M | 1.641M | 1.60% |
| Q4 2022 Q2Q % growth | 107.199M -8.48% | 113.06M | -5.861M | -5.18% |
| Q3 2022 Q2Q % growth | 108.637M 4.71% | 111.54M | -2.903M | -2.60% |
| Q2 2022 Q2Q % growth | 97.231M -6.54% | 105.58M | -8.349M | -7.91% |
| Q1 2022 Q2Q % growth | 97.529M 9.83% | 96.242M | 1.287M | 1.34% |
| Q4 2021 Q2Q % growth | 117.13M 0.37% | 112.07M | 5.06M | 4.52% |
| Q3 2021 Q2Q % growth | 103.747M 0.24% | 107.51M | -3.763M | -3.50% |
| Q2 2021 Q2Q % growth | 104.031M 16.37% | 94.316M | 9.715M | 10.30% |
| Q1 2021 Q2Q % growth | 88.8M 11.14% | 97.104M | -8.304M | -8.55% |
| Q4 2020 Q2Q % growth | 116.7M -7.60% | 114.19M | 2.51M | 2.20% |
| Q3 2020 Q2Q % growth | 103.5M -21.11% | 97.882M | 5.618M | 5.74% |
| Q2 2020 Q2Q % growth | 89.4M -12.52% | 87.968M | 1.432M | 1.63% |
| Q1 2020 Q2Q % growth | 79.9M 16.30% | 80.23M | -330K | -0.41% |
| Q4 2019 Q2Q % growth | 126.3M | 114.09M | 12.21M | 10.70% |
| Q3 2019 Q2Q % growth | 131.2M | 99.041M | 32.159M | 32.47% |
| Q2 2019 Q2Q % growth | 102.2M | 91.414M | 10.786M | 11.80% |
| Q1 2019 Q2Q % growth | 68.7M | 83.936M | -15.236M | -18.15% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 49.76% | 49.76% | -19.35% | -19.35% |
| Revenue | 1.45% | 1.45% | 0.38% | 0.38% |